Clinical Trial Update: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer [Phase 3]

View source ↗

Summary

This update reports the completion of the TRINOVA-1 Phase 3 trial evaluating AMG 386 in combination with weekly paclitaxel for fallopian tube cancer, ovarian ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• AMG-386 (trebananib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Amgen | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED